Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.49
+0.01 (0.01%)
At close: Jan 21, 2026, 4:00 PM EST
33.48
-0.01 (-0.01%)
After-hours: Jan 21, 2026, 4:10 PM EST
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
$478,186
Profits / Employee
-$726,568
Market Cap
2.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | 1,489 | 486 | 48.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GLPG News
- 16 days ago - Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - GlobeNewsWire
- 4 weeks ago - Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation - Seeking Alpha
- 6 weeks ago - Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025 - GlobeNewsWire
- 2 months ago - Galapagos Receives Transparency Notifications from Bank of America - GlobeNewsWire
- 2 months ago - Galapagos NV (GLPG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Galapagos to Present New Data from Cell Therapy Program at ASH 2025 - GlobeNewsWire
- 3 months ago - Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors - GlobeNewsWire
- 3 months ago - Biotech firm Galapagos to wind down cell therapy business - Reuters